A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects

• Main Authors: Ruirui Zhou (Author), Linfeng Guo (Author), Xianglei Gao (Author), Yijun Wang (Author), Wenjing Xu (Author), Yang Zou (Author), Wenjia Li (Author), Yulei Zhuang (Author), Gangyi Liu (Author), Yanmei Liu (Author)
• Format: Book
• Published: Wiley, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar (RD12014) compared to reference liraglutide (Victoza) in healthy Chinese male subjects, so as to provide the basis for the similarity evaluation of the two drugs. Eligible subjects were ran...